23andMe turns DNA data into drugs in startup’s latest twist

March 13, 2015 1:50 AM

8 0

23andMe turns DNA data into drugs in startup’s latest twist

23andMe, the Google-backed genetic-testing startup that popularized a $99 DNA spit test, will expand from screening people for diseases to inventing new medicine to cure them.

The Silicon Valley company has recruited a top biotechnology executive to help. Richard Scheller spent almost 15 years at Genentech, heading research and early development at the company that invented pioneering cancer drugs Herceptin and Avastin. He’ll lead 23andMe’s new therapeutics group.

Read more

To category page

Loading...